The Global Antidiuretic Drugs Market is predicted to touch USD 180 million at a 9.7% CAGR between 2017-2023, reveals the latest Market Research Future (MRFR) report. An antidiuretic, simply put, is a substance that helps in controlling fluid balance in the body by reducing urination. Following the rapid inception of modernization, people’s lifestyles too have undergone a drastic change. The prevalence of these health conditions is on the rise worldwide chiefly on account of the sedentary lifestyle. Moreover, the increasing prevalence of interstitial cystitis and urinary incontinence has also increased the demand for antidiuretic drugs. Oxytocin, desmopressin, and vasopressin, which is also popularly called ADH (antidiuretic hormone), are some of the most commonly used antidiuretic drugs. Of these, desmopressin is the most widely used as it is safe, relatively inexpensive, and has minimal adverse reactions. These drugs work wonders to reduce the volume of urine, a key indication of diabetes insipidus (DI).
Various factors are propelling the antidiuretic drugs market growth. These factors, as per the new Market Research Future (MRFR) report, include increasing prevalence of diabetes as well as other chronic diseases, especially cardiovascular diseases, huge patient pool having hypertension, increasing use of these drugs to treat hemophilia, and rising geriatric population. Additional factors pushing market growth include rapid developments in healthcare facilities, availability of advanced treatment options, and high incidence of conditions such as interstitial cystitis and urinary incontinence.
On the flip side, strict policies laid down by the different governing authorities and regulatory bodies is likely to hamper the antidiuretic drugs market growth over the forecast period.
Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/4306
The MRFR report provides an all-inclusive segmental analysis of the antidiuretic drugs market on the basis of types, end users, and indication.
Based on types, the antidiuretic drugs market is segmented into oxytocin, desmopressin, vasopressin, and others. The other types have been segmented into terlipressin, ornipressin, lypressin, and argipressin.
Based on indication, the antidiuretic drugs market is segmented into hypertension, hemophilia, diabetes insipidus, and others. The diabetes insipidus segment is again segmented into gestational diabetes insipidus, dipsogenic diabetes insipidus, nephrogenic diabetes insipidus, and central diabetes insipidus. The other indications have been segmented into enuresis, polydipsia, and polyuria.
Based on end users, the antidiuretic drugs market is segmented into pharmaceutical companies, clinics, hospitals, and others.
By region, the antidiuretic drugs market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa. The Americas have been categorized into North and South America. Of these, North America will dominate the market during the forecast period. Factors propelling growth in the region include increasing geriatric population with hypertension and diabetes, coupled with the increasing incidence of diabetes insipidus.
The antidiuretic drugs market in Europe is predicted to have the second-largest share in the market during the forecast period. This is chiefly on account of the accessibility of funds for research and development activities and the growing adoption of new drugs to treat diabetes insipidus.
The antidiuretic drugs market in the APAC region is predicted to grow at the fastest pace during the forecast period. Factors pushing growth in the region include the expanding healthcare system in the region’s developing countries and increasing awareness amongst consumers about the usage of antidiuretic drugs along with its side effects.
The antidiuretic drugs market in the Middle East and Africa is predicted to have steady growth over the forecast period chiefly due to the burgeoning demand for primary healthcare services.
Get Amazing Discount on Report: https://www.marketresearchfuture.com/check-discount/4306
Leading players profiled in the antidiuretic drugs market report include ALLERGAN (US), Taj Pharmaceuticals Limited (India), Otsuka Holdings Co. Ltd (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Azevan Pharmaceuticals, Inc. (US), ADH Health (US), and Par Sterile Products, LLC (US), among others. Key players have incorporated several strategies to cater to the growing needs of the customers and also strengthen their position in the market. These strategies include research and development activities, partnerships/joint ventures, collaborations, expansions, product launches and innovations, mergers and acquisitions, and many more.
TABLE OF CONTENT:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Antidiuretic Drugs Market, By Type
Chapter 7. Antidiuretic Drugs Market, By Diagnosis
Chapter 8. Antidiuretic Drugs Market, By Treatment
Chapter 9. Antidiuretic Drugs Market, By End-User
Chapter 10. Antidiuretic Drugs Market, By Region
Chapter 11. Company Landscape
Chapter 12 Company Profiles
Chapter 13 MRFR Conclusion
Chapter 14 Appendix
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312